Stories Library

We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.

Ear anatomy graphic

May 06, 2024

Hitting the “On Switch” in Hearing Loss

A novel gene therapy approach to switch on genetic drivers of hearing.

Clinical Research & Medicines, Research & Preclinical Development

An elderly woman talking to her grandchild.

February 01, 2024

Striving to Make a Big Impact in Cancer Care

How we are leading a charge to close the care gap in cancer treatment on World Cancer Day and everyday.

Clinical Research & Medicines

Debbie Allen (award-winning actress, dancer, and director) posing and smiling.

September 20, 2023

Prioritizing Eye Health With the Gr8 Eye Movement

Driving awareness for serious retinal diseases among impacted groups with a patient-focused disease awareness campaign.

Clinical Research & Medicines

Bari Kowal, REGENERON Senior Vice President, Head of Development Operations & Portfolio Management

June 26, 2023

Biomarkers Go Digital

Explore how we're modernizing clinical trials with digital biomarkers.

Clinical Research & Medicines

Woman holding a mug

May 23, 2023

Changing the Paradigm in COPD: Rethinking the Science & Removing Barriers

Committed to a patient-centered and science-forward approach.

Clinical Research & Medicines

Close-up of a person receiving an eye examination with medical equipment

April 17, 2023

Our Impact on Diseases of the Retina: Always Striving for Innovation

Regeneron’s unique impact on ophthalmology.

Clinical Research & Medicines

Technician studying infectious diseases

August 01, 2021

Moving at Pandemic Speed

Rapid response to infectious diseases.

Clinical Research & Medicines

Bispecific antibodies

December 02, 2020

Two Targets May Be Better Than One

Regeneron leaders Andres Sirulnik and Israel Lowy discuss why they believe bispecific antibodies may be the next class of medicines to revolutionize cancer treatment.

Clinical Research & Medicines, Research & Preclinical Development

A scientist working at a desk

November 21, 2020

The Regeneron Journey: 2020 Edition

Following an Emergency Use Authorization for casirivimab and imdevimab, Len Schleifer, MD, PhD, Founder and CEO, reflects on what the Regeneron team has accomplished so far in 2020.

Clinical Research & Medicines

3 individuals embracing one another

October 01, 2020

Listening & Learning From the Rare Disease Community

Doing right for those living with unmet needs.

Clinical Research & Medicines